Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients. Lissoni P, Malugani F, Casu M, Bukovec R, Egardi R, Bordin V, Fumagalli E, Mengo S, Gardani G. Clinical Trial 2002; 23(1): 61-63 PubMed PMID: 11880864 Keywords: Aged, Androgen Antagonists:therapeutic use, Anilides:therapeutic use, Humans, Levodopa, Male, Middle Aged, Nitriles, Prolactin:blood, Prostatic Neoplasms:blood, Tosyl Compounds,. Citation OBJECTIVES: The secretion of prolactin (PRL), which is a growth factor for prostate cancer cell proliferation, has been proven to present ..... Read abstract Full text PDF